90% of new cervical cancer cases are in low- and middle-income countries

(LMICs), and cervical cancer is the most common cancer among women in

Ghana. 95% of cervical cancers are caused by human papillomavirus (HPV), yet less than 3% of eligible population in Ghana have been screened for HPV. Current HPV screening methods, like pap smears, are expensive, invasive, and often require a male clinician in LMICs.

If HPV is present in a patient, the virus can be detected in the first 20 mL of their urine stream (first-void urine). Urine-based HPV tests on the market are expensive and inaccessible to underserved populations. This 3D printed HPV screening device is inexpensive and hands-free. It can also be manufactured on-site. I designed, fabricated, tested, and wrote clinician documentation for the device. I also co-authored a journal article on the development of the device.